Skip to main content
. Author manuscript; available in PMC: 2012 Jun 11.
Published in final edited form as: Melanoma Res. 2009 Oct;19(5):283–293. doi: 10.1097/CMR.0b013e32832b272d

Fig. 2.

Fig. 2

Concentration–effect curves of KP46 [tris(8-quinolinolato)gallium(III)], gallium nitrate, dacarbazine and cisplatin (MTT assay, 96 h exposure) in five human melanoma cell lines: 518A2 (a), 607B (b), A375 (c), MEL-JUSO (d), and SK-MEL-28 (e).